1 Dec 2025
Targeting TXNIP With Saroglitazar Mitigates Acute Hepatic Injury in Rats Challenged With Thioacetamide: A Multistep Computational and Experimental ApproachPublisher siteArchiv der Pharmazie, Redox biology and oxidative stress
Active, last published 2026
In inflammasome and immune disorders
Eman M. Abd
El-Kader
Scholar“Research focused on Inflammasome and immune disorders and adjacent fields.”
Claim Your Profile5
H-index
298
Citations
Eman has not officially claimed their profile. If you are Eman, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
man M. Abd El-Kader is a researcher working on Inflammasome and immune disorders. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Eman's work has been cited 298 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Inflammasome and immune disorders×3Drug-Induced Hepatotoxicity and Protection×2
04 · Where I am
Affiliations
Affiliation on published researchDelta University for Science and Technology, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
5 works12 May 2025Open access3cites
Verapamil inhibits TXNIP-dependent NLRP3 Inflammasome activation in an ulcerative colitis rat model: A new evolving role of the calcium channel blockerPublisher siteInternational Immunopharmacology, Inflammasome and immune disorders
7 Nov 20245cites
Diltiazem mitigates acute liver injury by targeting NFκB-TXNIP/NLRP3 axis in Rats: New insights beyond calcium channel blockadePublisher siteInternational Immunopharmacology, Drug-Induced Hepatotoxicity and Protection
4 Oct 20245cites
Metformin's cardioprotective role in isoprenaline-induced myocardial infarction: Unveiling insights into the AMPK, NF-κB, JAK2/STAT3 pathways, and cholinergic regulationPublisher siteLife Sciences, Metabolism, Diabetes, and Cancer
18 Sept 202062cites
Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signalingPublisher siteToxicology and Applied Pharmacology, Liver physiology and pathology
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Eman?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you